Biostage Stock Number Of Employees
Biostage fundamentals help investors to digest information that contributes to Biostage's financial success or failures. It also enables traders to predict the movement of Biostage OTC Stock. The fundamental analysis module provides a way to measure Biostage's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biostage otc stock.
Biostage |
Biostage OTC Stock Number Of Employees Analysis
Biostage's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Biostage Number Of Employees | 6 |
Most of Biostage's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biostage is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
CompetitionBased on the recorded statements, Biostage is currently employing 6.0 people. This is 99.95% lower than that of the Biotechnology sector and 98.88% lower than that of the Health Care industry. The number of employees for all United States stocks is 99.97% higher than that of the company.
Biostage Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biostage's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Biostage could also be used in its relative valuation, which is a method of valuing Biostage by comparing valuation metrics of similar companies.Biostage is currently under evaluation in number of employees category among its peers.
Biostage Fundamentals
Return On Equity | -4.92 | |||
Return On Asset | -2.11 | |||
Current Valuation | 78.64 M | |||
Shares Outstanding | 11.64 M | |||
Shares Owned By Insiders | 50.95 % | |||
Number Of Shares Shorted | 121.66 K | |||
Price To Earning | (0.16) X | |||
Price To Book | 28.47 X | |||
EBITDA | (8.36 M) | |||
Net Income | (7.98 M) | |||
Cash And Equivalents | 4.64 M | |||
Cash Per Share | 0.40 X | |||
Total Debt | 115 K | |||
Debt To Equity | 0.04 % | |||
Current Ratio | 2.26 X | |||
Book Value Per Share | (0.16) X | |||
Cash Flow From Operations | (2.63 M) | |||
Short Ratio | 3.35 X | |||
Earnings Per Share | (0.89) X | |||
Target Price | 3.0 | |||
Beta | -0.91 | |||
Market Capitalization | 73.82 M | |||
Total Asset | 1.87 M | |||
Retained Earnings | (65.78 M) | |||
Working Capital | 7.23 M | |||
Current Asset | 7.88 M | |||
Current Liabilities | 654 K | |||
Net Asset | 1.87 M |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Biostage OTC Stock
If you are still planning to invest in Biostage check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biostage's history and understand the potential risks before investing.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Equity Valuation Check real value of public entities based on technical and fundamental data |